I don't know what is Hillal's purpose or time horizon. If he is a "capital venturist" he may take the funds and move on if he has "better" opportunities. If he thinks the return to Cardica is still the best game available to him he will probably stay. There is a great deal of potential --ultimately if Cardica captures the stapler-cutter market and can even encroach on the sealing market, the potential is ~1-3 Billion annually. If they can capture 60 plus gross margins, and 15-20% net margins, the market cap should be ~$6.00 * P/E. If they can command a P/E of 15 that would be $90 per share. It may take 10 years to get there. That would indicate a 53% compounded rate of return from the current $1.25 / share over the next 10 years. Not bad, but well within the range of what venture capitalist would consider.
I agree GSA, Microcutter product line has phenominal growth potential. Someone on the board posted that AMC was in the midst of hiring several new sales employees this summer and fall, their hypothesis was for the up comming introduction of the Microcutter (exchage 30) for 2014. "The 5MM
solution" was their marketing piece. Without the Microcutter Hillal might have some explaining to do
with his board. If AMC can't offer "Right Price" He might try to make things very difficult for CRDC
in future share offerings or "Private placements" ie. low share price and much more dilution.
I was inquiring whether AMC would try to Adversely affect rising share price as a form of negotiating tactic or ploy for strategic partnership. Not profit taking. I believe Amc bought their original block of shares @ 1.45. Hillal's last share dump effectively stopped all upward price momentum in its tract.